Mark Shteiman - 15 Jun 2026 Form 4 Insider Report for Allot Ltd. (ALLT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Jun 2026, 09:40:28 UTC
Prior SEC filing
26 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact

Key filing fact

Mark Shteiman filed Form 4 for Allot Ltd. (ALLT) on 16 Jun 2026.

Key facts

  • This page summarizes Mark Shteiman's Form 4 filing for Allot Ltd. (ALLT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2026, 09:40.

Change

  • Previous filing in this sequence was filed on 26 May 2026.
  • Current net transaction value: -$15,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002072237 Primary reporting owner

Shteiman Mark

Relationship
Chief Product Officer
Address
PROF. EFRAIM KATZIR 23/78, REHOVOT
Signature
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact
Signature date
16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLT transaction

Ordinary shares

Sale

Transaction value
$15,000
Shares
-2,000
Change %
-0.93%
Price
$7.50
Shares after
212,000
Date
15 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .